Example: stock market
Reflection paper on classification of advanced …
21 May 2015 . EMA/CAT/600280/2010 rev.1 . Committee for Advanced Therapies (CAT) Reflection paper on classification of advanced therapy medicinal products
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Advanced Therapy Medicinal Products (ATMPs)
www.ich.orgAn agency of the European Union Presented by: B. Brake and A. Ganan Jimenez European Medicines Agency Advanced Therapy Medicinal Products (ATMPs)
Guideline on strategies to identify and mitigate …
www.ema.europa.euThe revision is intended to further assist stakeholders in the transition from non -clinical to early clinical development and in identifying factors influencing risk for new investigational medicinal products
別紙（3） PIC/S GMPガイドライン アネックス2
www.pref.kagawa.lg.jp別紙（3） pic/s gmpガイドライン アネックス2 原文 和訳 manufacture of biological medicinal substances and products for human use
Since 1874 遺伝子治療用製品の開発における 国内 …
www.nihs.go.jpJanuary 6, 2012 From: the American Society of Gene & Cell Therapy and all the Society’s past Presidents To: NIH Director, Francis S Collins